In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

Of all the wonder drugs in the history of medicine, insulin may be the closest parallel, in both function and purpose, to this century’s miracle of a metabolic drug: the GLP-1 agonist.

Opens in a new tab or window SAN DIEGO -- Type 2 diabetes patients may have a lower risk of venous thromboembolism (VTE) when treated with a GLP-1 receptor agonist, regardless of their obesity ...

China represents an untapped market for GLP-1 class diabetes drugs ... strong demand for diabetes drugs and insulins as the century progresses. Victoza is competing against several other companies ...